Perflutren Lipid Microspheres Suspension For Injection 2Ml Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Perflutren Lipid Microspheres: Suspension for injection (2mL)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PERFLUTREN PROTEIN-TYPE A MICROSPHERES is a contrast agent. It is used to diagnose abnormalities during an ultrasound of the heart.

In-Depth Information

Definity Suspension for Injection

NDC: 119940011
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Echocardiography, Ultrasound Imaging

Storage Information
Refrigerate (between 36 and 46 degrees F)
Definity Suspension for Injection

Reported Side Effects for Definity Suspension for Injection

Stomach Pain Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
No White Blood Cells Incidence:
<0.5%*
Severity: SEVERE
Onset: DELAYED
High White Blood Cells Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<0.5%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
<0.5%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Eosinophilia Incidence:
<0.5%*
Severity: MODERATE
Onset: DELAYED
Deafness Incidence:
<0.5%*
Severity: SEVERE
Onset: DELAYED
Bruise Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Excessive Mucle Tone Incidence:
<0.5%*
Severity: MODERATE
Onset: DELAYED
Hypoxia Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<0.5%*
Severity: MODERATE
Onset: RAPID
Joint Pain Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
<0.5%*
Severity: SEVERE
Onset: RAPID
Cough Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
<0.5%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<0.5%*
Severity: MILD
Onset: RAPID
Itching Incidence:
<0.5%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
<0.5%*
Severity: MODERATE
Onset: RAPID
High Blood Pressure Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Excessive Sweating Incidence:
<0.5%*
Severity: MILD
Onset: DELAYED
Hot Flashes Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
0.6%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
0.8%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
1.1%*
Severity: MILD
Onset: RAPID
Back Pain Incidence:
1.2%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Long Qt Syndrome Incidence:
29.0%*
Severity: MODERATE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Perflutren Lipid Microspheres

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit
your own observations and experiences to benefit others.